Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
RPID Transcript
Rapid Micro Biosystems, Inc. (RPID) Q1 2026 Earnings Call Transcript
Unknown5-13
The earnings call shows mixed signals: while there are positive developments like the Millipore JV expansion and potential margin improvements, there are also concerns such as increased net loss, operating expenses, and management's reluctance to provide clear guidance on key issues. The Q&A reveals cautious optimism but also highlights uncertainties. The lack of strong catalysts and the mixed guidance suggest a neutral impact on the stock price over the next two weeks.
Rapid Micro Biosystems, Inc. (RPID) Q4 2025 Earnings Call Transcript
Unknown3-12
The earnings call presents a mixed outlook. Positive aspects include increased consumable and recurring revenue, raised revenue guidance for 2025, and promising partnerships. However, concerns arise from inventory charges impacting margins, a widening net loss, and vague management responses in the Q&A. The lack of specific data on CDMO placements and Samsung orders adds uncertainty. While there are growth drivers, the immediate financial health and unclear guidance temper expectations, resulting in a neutral sentiment.
Rapid Micro Biosystems, Inc. (RPID) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-15
Rapid Micro Biosystems, Inc. (RPID) Q3 2025 Earnings Call Transcript
Positive11-7
The earnings call revealed positive signs such as a guidance raise due to a large multi-system order, consistent global demand, and improved service margins. Despite a net loss, operating expenses decreased, and cash reserves are strong. The MilliporeSigma partnership and high ROI investments further bolster the outlook. However, management's lack of clarity on some order specifics and onshoring timelines tempers enthusiasm. Overall, the positive factors outweigh the negatives, suggesting a stock price increase in the near term.
RPID Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.